Header image

Repackaged Drug Recall

Posted by Admin in Drug Recalls - (0 Comments)

repackaged drugs recallAidapak Services is a facility that repackages drug and markets the kits to hospital pharmacies and health care professionals.  There may have been some cross-contamination at their plant recently, when some drugs repackaged in that facility may have entered the recalled products, which are listed on the FDA’s website, which tells of the repackaged drug recall.

Patients who are hypersentitive to penicillin products may be at risk of anaphylactic reaction if administered the contaminated drugs from the repackaged kits.  The Repackaged Drug Recall urges hostipals, clinics and any healthcare facility using recalled Aidapak Services products to stop using them immediately.

,

Slim XTreme Recall

Posted by Admin in Supplement Recalls - (0 Comments)

Slim XTreme RecallThe FDA has issued a voluntary recall of a dietary supplement that has not been approved by them.  The Slim XTreme recall is due to an undeclared ingredient, which the company has not received approval to market.  The safety and effectiveness of the undeclared ingredient has not been determined, and FDA protocol for this situation is a recall.

The undeclared ingredient at the heart of this Slim XTreme recall is called Sibutramine.  The actual wording of the FDA recall is that the ingredient does not cover Globe All Wellness, Inc.,  the manufacturer’s,  other products.   The specific recall is for Slim Xtreme™ Herbal Slimming Capsule 30 Capsules/Bottle. The recalled weight loss pills were actually sold by a company that was not authorized by Globe All Wellness, Inc.

Sibutramine poses a danger to the health of some people.  It can cause a great risk for people with a history of coronary artery disease, stroke, high blood pressure, arrhythmias, or congestive heart failure.

Consumers are urged to return Xlim Xtreme Herbal Slimming Capsule to the headquarters of Globe All Wellness in Hollywood, FL.  The Slim Xtreme recall is a voluntary recall and the company is working with the FDA to ensure the product is safely removed from the market.

, , , ,

Pentrexyl Forte Natural Recall

Posted by Admin in Supplement Recalls - (0 Comments)

Supplement RecallPentrexyl Forte Natural is a dietary supplement that’s marketed to look like an antibiotic.  Who would fall for such?  Well, Spanish speaking immigrants living in Texas, apparently.  Phoenix Import & Distribution, makers of the supplements, and the company issuing the Pentrexyl Forte Natural recall, apparently aimed their faux antibiotic to Spanish speakers who knew the original product from Mexico.

Press releases for the Pentrexyl Forte Natural recall state the packaging for the product is misleading.  The danger, according to the FDA, is that consumers may buy it, thinking they’re getting an antibiotic.  This delays real treatment for what could be a serious illness.

The product is being sold in retail stores throughout Texas, and is voluntarily recalled so people don’t confuse it with other products.  The product is recalled after a similar situation was announced last week, also in Texas.  Another herbal dietary supplement was recalled because health officials said it was marketed, packaged, and sold to resemble a real over the counter antibiotic that’s sold in Mexico.

A lawsuit was apparently filed in Texas over Pentrexyl Forte Natural’s allegedly intentional resemblance to a well known pharmaceutical product.

Consumers who purchased the herbal supplement can return it for a full refund, stated in terms of the Pentrexyl Forte Natural recall.

 

 

, ,

Ammonium Molybdate Recall

Posted by Admin in Drug Recalls - (0 Comments)

ammonium molybdate recallLuitpold Pharmaceuticals, Inc. has announced a drug recall involving its Ammonium Molybdate.   American Regent, the distributor of the drug, announced the voluntary drug recall last month.  The Ammonium Molybdate recall was issued after some lots of the drug were found to have particulate matter in them.

Only one lot of Ammonium Molybdate was released to the public, and those who purchased the drug should stop using it immediately.  They should contact American Regent and return the recalled product.  Particles in injectable medicine cause problems when they block blood flow in small blood vessels.  This can cause inflammation and also formation of granuloma.

The Ammonium Molybdate recall covers single dose injections of the drug, which is an injection given as a supplement to Total Parenteral Nutrition (TNP).  TNP is when a patient is fed intravenously, and food is given no other way.  This is usually the procedure when a patient has gastrointestinal dysfunction, so that whole route for food is bypassed and nutrition is given totally intravenously.

As with any injectable drug given in a hospital setting, that packaging instructs medical professionals to check the vial for particulate matter.  Sometimes, however, the particles are so small they are difficult if not impossible to see.  They can even be microscopic.

 

,

Prezista Recall

Posted by Admin in Drug Recalls - (0 Comments)

prezista recallJohnson & Johnson has been involved again in a drug recall, again because of musty odors observed when pill bottles are opened.  And once again, the cause is wooden pallets.  This time, it’s a Prezista recall, after reports of musty odors came from four people.  The odors were also associated with another Johnson & Johnson recall, Topamax.  Topamax is an antiseizure drug recalled last month after similar reports of musty odors.

The culprit once again is TBA, which is the byproduct of a preservative used to treat wood in pallets.  The odor leaches in pill bottles stored on the pallets and escapes when consumers open the bottle after purchase.  There is no known serious health danger, even though there have been a few reports of gastrointestinal discomforts.

The Prezista recall will affect HIV/AIDs patients, who are prescribed the drug because it is a protease inhibitor.

Johnson & Johnson has also had reports of the foul odor coming form Tylenol and Motrin, plus a few other drugs as well.  The giant drug company is looking into the matter.  They have asked their suppliers to verify they are not using wooden pallets that have been chemically treated. Self Employment Tax Irs Tax Brackets IRS form 941

, , , ,

Multi-Mex Supplement Recall

Posted by Admin in Supplement Recalls - (0 Comments)

Multi-Mex Supplement RecallDietary supplements manufactured by Multi-Mex Distributor, Inc. are being recalled by the Tucker, GA company.  Consumes, especially Hispanic consumers, may believe they are purchasing antibiotics.  Reasons for the voluntary Multi-Mex supplement recall include the fact that the supplements are packaged to resemble an over the counter antibiotic sold in Mexico.  Hispanics who are familiar with the antibiotic in Mexico may be mistakenly purchasing the dietary supplement sold in the United States, and giving it to their children or themselves, thus delaying real treatment for serious conditions.

The Multi-Mex supplement recall was initiated after four children in Texas were given the supplement when what they needed was an antibiotic.  The instructions on the label are printed in both English and Spanish, but the packaging is allegedly almost identical to that of the antibiotic OTC drug sold in Mexico that in a stressful situation (i.e. when your child is sick and you’re in a hurry) can easily be mistaken for the wrong thing.

Some of the dietary supplements mistaken for Amoxicillin are actually similar in name: AMOXILINA CAPSULS.   After incident involving the four sick children in Texas, the FDA carried out inspections on the Multi-Mex dietary supplements and found that the packaging mimics the original antibiotic sold in Mexico.  The FDA believes it was an intentional marketing strategy and that it was aimed at hispanics.

 

, ,

Caffeine and Sodium Benzoate Recall

Posted by Admin in Drug Recalls - (1 Comments)

Caffeine and Sodium Benzoate RecallA nationwide voluntary recall of caffeine and sodium benzoate injections manufactured by American Regent was issued this week.  The Caffeine and Sodium Benzoate recall was issued after particulate matter was found in some doses. Some of the vials contain foreign matter, or particulates, which can cause serious harm to the patient if injected along with the medicine.

The vials of lot # 0084 are included in the Caffeine and Sodium Benzoate recall, which does not include any other lots of the injectable drug.  The particulates are visible, and intravenous introduction into the body can cause serious harm.  Particulates in Caffeine and Sodium Benzoate injections can cause disruption to the flow of blood in small blood vessels in the lungs.  If the drug is injected into the muscle, it can cause a response by the body that causes pain, swelling, and something called local granuloma formation.

Caffeine and Sodium Benzoate injections are given in cases of respiratory depression.  This occurs when a patient has overdosed on narcotics, pain killers or alcohol.

Boxes of vials containing Caffeine and Sodium Benzoate injections come with a warning for doctors and nurses to inspect the vial for particulates and discoloration before using.  However, American Regent is investigating the matter even as it pulls lot # 0084 off the shelves.

 

,

Coumadin Recall

Posted by Admin in Drug Recalls - (0 Comments)

Coumadin recallCoumadin, the blood thinner made by Bristol-Myers Squibb, has been recalled by the FDA.  The Coumadin recall, issued last Monday, comes after Bristol-Myers Squibb labs randomly tested a Coumadin pill and found it to have a much higher strength than indicated on the label, and much higher than intended by the drug company.

The extra strength tablets of Coumadin could cause a potentially fatal overdose of blood thinner.  An extra dose of blood thinner can have serious health implications even if it does not lead to a fatal situtation, as with any drug.   The bottles involved in this particular Bristol-Myers Squibb recall are the 5 mg tablets sold in 1,000 pill bottles.  They are sold in smaller bottles from pharmacies, by prescription only.

Coumadin is also called warfarin, and is given to patients to prevent embolisms and blood clots.  A Coumadin overdose can cause excessive bleeding in patients, and is a very serious situation.  So far, there have been no reports of this happening.

The first Coumadin recall occurred last July, when 1 mg pills were recalled.  They were found to be unstable, with the potency of the pills fluctuating.  The cause was found to be use of a cheap ingredient, isopropanol, which is used to keep the active ingredient in its proper state.

, , ,

Topamax Recall

Posted by Admin in Drug Recalls - (0 Comments)

topamax-recallOrtho-McNeil has recalled tens of thousands of bottles of the anti-seizure drug Topamax after reports of foul odors came in.  This is a repeat version of an earlier Topamax recall, also caused by uncharacteristic odors.  The parent company of Ortho-McNeil, Johnson & Johnson, is recalling 57,000 bottles of 100-milligram tablets of Topamax with expiration dates between June 2012 and September 2010.

This is not the first Topamax recall Johnson & Johnson has been through…earlier this year the company issued a drug recall involving Topamax taken by pregnant women who are higher risk of giving birth to babies with cleft palate.

This latest Topamax recall, which came late last week, involves the wooden palates on which the drug was stored and shipped.  Apparently the wood used to make the palates is treated with a chemical known as TBA (chemists know it as 2,4,6-tribromoanisole), which gives off an odor.  The odor can be absorbed by whatever is stored on it or nearby.

The odor, which is described simply as an uncharacteristic odor, has not seriously harmed anybody yet, but some patients taking Topamax have reported gastrointestinal discomfort.  The shipments affected in the Topamax recall were shipped October and December 2010.

, , , , , , ,

Infusion Pump Recall

Posted by Admin in Class I Recalls - (0 Comments)

infusion pumpThe FDA has classified the latest infusion pump recall as a Class I, the agency’s most serious level of recall.  The Curlin Ambulatory Infusion Pumps made by Moog in East Aurora, NY have malfunction problems that can lead to serious injury or death, so are officially now classified as Class 1 by the Federal Drug Administration.

This is just the latest in a series of infusion pump recalls over the past year, all concerning malfunctioning of the pump which leads to not enough or too much drug delivered into the patient’s system at once.

The infusion pump recall affects products made from May 2007 to February 2011 with the names Curlin and also PainSmart.  There is actually software that’s part of the pump device, which malfunctions and causes error code 45.  That error shuts down the pump, which will result in the patient failing to receive medication.  Since that can lead to serious injury or death, the FDA has classified the voluntary recall of the infusion pumps as a Class I recall.

,